Plan to attend the third
Please join us in at the Westin Ottawa, Ontario as we host the third Canadian Symposium on Lysosomal Diseases (CSLD). We invite Physicians, Researchers, Registered Nurses, Genetic Counsellors and Trainees who share an interest in the specialty of lysosomal diseases to attend this in-person Symposium. A virtual platform will be available for guests who are unable to attend in-person.
The theme for this meeting is
Canadian and international leaders and experts will present innovative trends and solution-focused best practices in the diagnosis and management of lysosomal diseases.
We look forward to welcoming you to Ottawa!
CSLD 2024 offers an unprecedented opportunity to advocate for your organization by partnering with us. Investment impact for your organization at CSLD 2024 includes but is not limited to:
All fees are stated in Canadian dollars (CAD).
To confirm your commitment or learn more about opportunities to support CSLD 2024, please contact .
Third Annual Canadian Symposium on Lysosomal Diseases (CSLD)
Lysosomal diseases (LSDs) are a group of rare inherited metabolic disorders characterized by the dysfunction of lysosomes, cellular organelles responsible for breaking down various substances. In LSDs, there is a deficiency of specific enzymes within the lysosomes, leading to the accumulation of undigested materials inside the cells. This accumulation can cause damage to tissues and organs throughout the body.
There are more than 50 different types of LSDs, each associated with a specific enzyme deficiency and a unique set of symptoms. Examples of LSDs include Gaucher disease, Fabry disease, Niemann-Pick disease, and Pompe disease.
The Canadian Symposium on Lysosomal Diseases (CSLD Symposium) is an event focused on bringing together experts, researchers, clinicians, genetic counsellors, and other stakeholders to discuss the latest advancements, research findings, and treatment options related to lysosomal diseases. Attending the Canadian Symposium on Lysosomal Diseases can offer several benefits, including:
Education: Participants can gain insights into the current state of research and treatment options for lysosomal diseases. Experts in the field may present new findings, methodologies, and approaches to managing these rare disorders.
Networking: The Symposium provides an opportunity for professionals and individuals involved in the field of lysosomal diseases to connect with one another. Networking can foster collaboration, information sharing, and the development of new research initiatives.
Advocacy and Awareness: The Symposium may include discussions on advocacy efforts and raising awareness about lysosomal diseases. Increased awareness is crucial for fostering research, securing funding, and improving the overall understanding of these rare disorders.
Professional Development: Healthcare professionals, researchers, scientists, and other stakeholders attending the CSLD will advance their professional development, grow their knowledge and create collaborations that may be applied in their work to enhance patient care and outcomes.
If you are involved in the field of lysosomal diseases or have a personal or professional interest in these disorders, attending the CSLD Symposium could be a valuable opportunity to stay informed, connect with others in the field, and contribute to the ongoing efforts to improve the lives of individuals affected by LSDs.